Correspondence
The immortal Ologen: persisting 10 years after trabeculectomy
The surgical management of glaucoma has been evolving over the past few decades. In an attempt to improve the results of trabeculectomy, a number of modifications have been tried, of which Ologen (Aeon Astron, Leiden, The Netherlands) is one adjunct.1,2 Ologen is being extensively used for filtering surgeries and is known to undergo complete biodegradation within 90–180 days of implantation.3 We report a case of trabeculectomy failure in both eyes (BE) of a patient who had undergone augmented trabeculectomy with Ologen, which was seen to be retained for 10 years postsurgery.Posterior lens capsular neovascularization of young: management using endodiathermy assisted biopsy
Neovascularization of lens capsule has so far been described in cases of retinal detachment or proliferative diabetic retinopathy in pseudophakes.1–4 We hereby describe a unique case that presented with posterior lens capsular neovascularization in the absence of any other sign of anterior segment neovascularization, and it was found to be associated with idiopathic ciliary body inflammation. The management with regard to clearing of the visual axis, biopsy of the involved tissue, and follow-up is described.
